Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07230132 |
| Consolidated Lead Sponsor | Beijing QL Biopharmaceutical Co |
| Therapeutic Condition Cohort | Endocrinology, Obesity, and Metabolic |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 184 participants (ACTUAL) |
| Registered Start Date | 2025-12-12 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The Second Affiliated Hospital of Nanjing Medical University | Nanjing, China | Open Hospital Dossier -> |
| First Hospital of Shanxi Medical University | Taiyuan, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.